Drugs and Devices

FDA approves generic Strattera for ADHD

On May 30, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Read more 


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares